Literature DB >> 20577002

SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations.

Stéphanie Millecamps1, François Salachas, Cécile Cazeneuve, Paul Gordon, Bernard Bricka, Agnès Camuzat, Léna Guillot-Noël, Odile Russaouen, Gaëlle Bruneteau, Pierre-François Pradat, Nadine Le Forestier, Nadia Vandenberghe, Véronique Danel-Brunaud, Nathalie Guy, Christel Thauvin-Robinet, Lucette Lacomblez, Philippe Couratier, Didier Hannequin, Danielle Seilhean, Isabelle Le Ber, Philippe Corcia, William Camu, Alexis Brice, Guy Rouleau, Eric LeGuern, Vincent Meininger.   

Abstract

BACKGROUND: Mutations in SOD1, ANG, VAPB, TARDBP and FUS genes have been identified in amyotrophic lateral sclerosis (ALS).
METHODS: The relative contributions of the different mutations to ALS were estimated by systematically screening a cohort of 162 families enrolled in France and 500 controls (1000 chromosomes) using molecular analysis techniques and performing phenotype-genotype correlations.
RESULTS: 31 pathogenic missense mutations were found in 36 patients (20 SOD1, 1 ANG, 1 VAPB, 7 TARDBP and 7 FUS). Surprisingly two FUS mutation carriers also harboured ANG variants. One family of Japanese origin with the P56S VAPB mutation was identified. Seven novel mutations (three in SOD1, two in TARDBP, two in FUS) were found. None of them was detected in controls. Segregation of detected mutations with the disease was confirmed in 11 families including five pedigrees carrying the novel mutations. Clinical comparison of SOD1, TARDBP, FUS and other familial ALS patients (with no mutation in the screened genes) revealed differences in site of onset (predominantly lower limbs for SOD1 and upper limbs for TARDBP mutations), age of onset (younger with FUS mutations), and in lifespan (shorter for FUS carriers). One third of SOD1 patients survived more than 7 years: these patients had earlier disease onset than those presenting with a more typical course. Differences were also observed among FUS mutations, with the R521H FUS mutation being associated with longer disease duration.
CONCLUSIONS: This study identifies new genetic associations with ALS and provides phenotype-genotype correlations with both previously reported and novel mutations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577002     DOI: 10.1136/jmg.2010.077180

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  87 in total

1.  Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors.

Authors:  Sung Min Han; Hiroshi Tsuda; Youfeng Yang; Jack Vibbert; Pauline Cottee; Se-Jin Lee; Jessica Winek; Claire Haueter; Hugo J Bellen; Michael A Miller
Journal:  Dev Cell       Date:  2012-01-19       Impact factor: 12.270

2.  Questioning on the role of D amino acid oxidase in familial amyotrophic lateral sclerosis.

Authors:  Stéphanie Millecamps; Sandra Da Barroca; Cécile Cazeneuve; François Salachas; Pierre-François Pradat; Véronique Danel-Brunaud; Nadia Vandenberghe; Lucette Lacomblez; Nadine Le Forestier; Gaëlle Bruneteau; William Camu; Alexis Brice; Vincent Meininger; Eric LeGuern
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-10       Impact factor: 11.205

Review 3.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

Review 4.  Autophagy as a common pathway in amyotrophic lateral sclerosis.

Authors:  Dao K H Nguyen; Ravi Thombre; Jiou Wang
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

Review 5.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

6.  Angiogenin inhibits nuclear translocation of apoptosis inducing factor in a Bcl-2-dependent manner.

Authors:  Shuping Li; Wenhao Yu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

7.  Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene.

Authors:  Adriano Chiò; Giuseppe Borghero; Maura Pugliatti; Anna Ticca; Andrea Calvo; Cristina Moglia; Roberto Mutani; Maura Brunetti; Irene Ossola; Maria Giovanna Marrosu; Maria Rita Murru; Gianluca Floris; Antonino Cannas; Leslie D Parish; Paola Cossu; Yevgeniya Abramzon; Janel O Johnson; Michael A Nalls; Sampath Arepalli; Sean Chong; Dena G Hernandez; Bryan J Traynor; Gabriella Restagno
Journal:  Arch Neurol       Date:  2011-01-10

8.  Genetic Counseling Dilemmas for a Patient with Sporadic Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration & Parkinson's Disease.

Authors:  Vittorio Mantero; Claudia Tarlarini; Angelo Aliprandi; Giuseppe Lauria; Andrea Rigamonti; Lucia Abate; Paola Origone; Paola Mandich; Silvana Penco; Andrea Salmaggi
Journal:  J Genet Couns       Date:  2017-03-01       Impact factor: 2.537

9.  Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia.

Authors:  Ivan V Marjanović; Biljana Selak-Djokić; Stojan Perić; Milena Janković; Vladimir Arsenijević; Ivana Basta; Dragana Lavrnić; Elka Stefanova; Zorica Stević
Journal:  J Neurol       Date:  2017-04-25       Impact factor: 4.849

10.  Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.

Authors:  Serena Lattante; Stéphanie Millecamps; Giovanni Stevanin; Sophie Rivaud-Péchoux; Carine Moigneu; Agnès Camuzat; Sandra Da Barroca; Emeline Mundwiller; Philippe Couarch; François Salachas; Didier Hannequin; Vincent Meininger; Florence Pasquier; Danielle Seilhean; Philippe Couratier; Véronique Danel-Brunaud; Anne-Marie Bonnet; Christine Tranchant; Eric LeGuern; Alexis Brice; Isabelle Le Ber; Edor Kabashi
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.